AbbVie proclaimed that it has finalized a deal with Samsung Bioepis and their joint venture partner Biogen Inc. that would deter U.S. competition of their biosimilar version to blockbuster drug Humira (Adalimumab) until 2023. This would mark the second deal AbbVie has made in the past year, trying to protect patents on their favorable drug, Humira.
Oxfordshire-based injection moulding group White Horse Plastics is extending its reach into the med-tech sector with the tooling and manufacture of luer connectors.
Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.
Researchers at ITMO University developed a new approach for obtaining non-toxic magnetic photonic crystals, expanding their applications from mainly photonics to biomedicine. Nanospheres made with the new method may be used for designing drugs to fight thrombosis and cancer.
Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Advanced Accelerator Applications (NASDAQ:AAAP) is a radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicines including Lutathera®
Only Healthcare Packaging EXPO gives your company exposure to the mega-audience of PACK EXPO Las Vegas—30,000 buyers from virtually every vertical market. The world’s top CPGs send engineers and managers to PACK EXPO in search of innovative approaches to packaging and production. It’s a great opportunity to offer creative applications for your product.
